A novel amplification at 17q21-23 in ovarian cancer cell lines detected by comparative genomic hybridization

Gynecologic Oncology

Volumn 81, Issue 2, 2001, Pages 172-177

  Watanabe, Takafumi ^a,b   Imoto, Issei ^a   Kosugi, Yoshinori ^a,c   Ishiwata, Isamu ^d   Inoue, Satoshi ^e   Takayama, Masaomi ^c   Sato, Akira ^b   Inazawa, Johji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d Yoneyama Obstetrics and Gynecology Hospital   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Comparative genomic hybridization (CGH); Gene amplification; Ovarian cancer; PS6K; ZNF147

Indexed keywords

DNA;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 17Q; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

EID: 0035015609     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6132     Document Type: Article

References (42)

1. Erratum: Estimates of the worldwide mortality from 25 cancers in 1990
2. Chromosome abnormalities in ovarian adenocarcinoma. I. Nonrandom chromosome abnormalities from 244 cases
3. Prognostic impact of chromosome aberrations in ovarian cancer
4. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
5. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: The possible involvement of the DPI gene in the 13q34 amplicon
6. Identification of a novel gene, MASL 1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization
7. Genetic analysis of benign, low-grade, and high-grade ovarian tumors
8. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer
9. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas
10. Identification of amplified DNA sequences on double minute chromosomes in a leukemic cell line KY821 by means of spectral karyotyping and comparative genomic hybridization
11. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization
12. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer
13. Chromosome mapping of human (ZNFI47) and mouse genes for estrogen-responsive finger protein (efp), a member of the RING finger family
14. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer
15. Increased copy number at 20q13 in breast cancer: Defining the critical region and exclusion of candidate genes
16. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors
17. Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: Intratumoral molecular heterogeneity
18. Deletion mapping of chromosome 11 in carcinoma of the bladder
19. Allelic loss and replication errors at microsatellite loci on chromosome lip in head and neck squamous carcinoma: Association with aggressive biological features
20. Microsatellite instability at a single locus (D11S988) on chromosome 11p15.5 as a late event in mammary tumorigenesis
21. PIK3CA is implicated as an oncogene in ovarian cancer
22. Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions
23. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization
24. p70s6k function is essential for 1GI progression
25. Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein
26. Endocrine factors in common epithelial ovarian cancer
27. Establishment and characterization of two human ovarian endometrioid carcinoma cell lines (with or without squamous cell component)
28. Characterization of newly established cell line HUOA from a human ovarian serous cystadenocarcinoma
29. Establishment and characterization of two human ovarian mucinous cystadenocarcinoma cell lines (HMKOA)
30. Characterization of newly established human ovarian carcinoma cell line: Special reference of the effects of cis-platinum on cellular proliferation and release of CA125
31. Establishment and characterization of a human ovarian anaplastic carcinoma cell line
32. Establishment and characterization of a human ovarian endometrioid carcinoma cell line (HIOAnu)
33. Tumor angiogenesis factors produced by cancer cells
34. Establishment and characterization of a cell line derived from mucinous cystadenocarcinoma of human ovary
35. Biological characterization including sensitivity to mitomycin C of cultured human ovarian cancers
36. Establishment and characterization of a permanent cell line from a human teratocarcinoma
37. Establishment of a cell line from human ovarian cancer (undifferentiated carcinoma of FIGO classification) and analysis of its cell-biological characteristics and sensitivity to anticancer drugs
38. Isolation of cisplatin-resistant subline from human ovarian cancer cell line and analysis of its cell-biological characteristics
39. Establishment and characterization of a human chorionic gonadotropin (hCG) producing cell line (RTSG) from an ovarian epithelial cancer
40. Establishment of a human ovarian clear cell carcinoma cell line (RMG-I) and its single cell cloning: With special reference to the stem cell of the tumor
41. A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II)
42. Biological properties of two newly established cell lines (RMUG-S, RMUG-L) from a human ovarian mucinous cystadenocarcinoma